{"name":"InMed Pharmaceuticals Inc.","slug":"inmed-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":4942633,"revenueGrowth":7.5,"grossMargin":0,"rdSpend":2853920,"netIncome":-8162133,"cash":15580040,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-04-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNRXZJUFFPSTU3MzV4SHpLc0hpSVh3ZzcyT041eGoxc0ZVY0czNlBXcXRZcHpHZTUwejJybEtyVmdWNElLTm9ta1pKRzV4bDlnOHA1RHI2ZDEwTmhaRmZFcXRjdmtaNDVDNHBKQ2t2Vmx1WFAwSmZTWUpYMktJUmhyc3hZM1V5ZzR1MlZiSHVVQnpXbmRCeTE2ZmMxSVVLX3pFVEFCZl9oTE82alQ4eHlPdTl5dEJjT2s?oc=5","date":"2026-03-27","type":"pipeline","source":"investingnews.com","summary":"InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance - investingnews.com","headline":"InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxObVJ0T3kyU1ZLRkxoamFDc2xJNFB6akR0UVN3RHBkYUZoOUpSZnZmakxjN1IzZlN1QS1qNExRZHJaeVM3OFdaaVM2ckl4TEFBUFNRcGoxcmpDZXMtdFYxZGxmcU8xT3VRRm1BNkp4TzRkZkhCRy1lMC1kZnVITk1nQzQwUmwyWlBjZHBiVWZsdk5XemU2MF8zU3djUWozSUtCazJDbDZtZzAyWlYzZGdQcm12SkRqR3Z0dE9QdmZMRXFLc1hISlVHX2YzZDgta2d0ZHZ2OXhMWkQ0dnhkY08xUWplWDRjS0NRREFBMldqMkJZSDcwcEpGbjcxTmRKSVNLNzVJNQ?oc=5","date":"2026-03-23","type":"trial","source":"investingnews.com","summary":"InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program - investingnews.com","headline":"InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 ","sentiment":"positive"},{"date":"2026-03-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPeHJrR1dmU3RFT1pTMlZUMlotMmE4cHQ3Q2RxdW1TRmZ2THhWc0owRHQ4WGxHRVdUSGFjSGdObmRCcGZLWm9lQlhFWUtTSXFGbjc5MnlrZGhuTUZkV2FCRkpmSXhDX1dWOEVxWlZyckMyYjl1Ykd6aDdPdkkxemQ5WUszX2I3SDR3Sk4wUkFUUF81RnZuZ1RMbEhUWGROLTRFZ0k3VWhnTFdlVmlFRUg2YW1PS1o?oc=5","date":"2026-03-09","type":"pipeline","source":"Stock Titan","summary":"InMed (INM) sets 2026 goals for Alzheimer’s and eye-disease drug programs - Stock Titan","headline":"InMed (INM) sets 2026 goals for Alzheimer’s and eye-disease drug programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOYUljTVpoSWkwTGowU3JsMW04aFJURkZWYTVYbGdkNVA5Uzg2UkxsSHM3cTdQTVNLS1Y4MTlUcmllSGloR1RhRGtCR1RULUY4MktEWlBtNnlnVXRfM0NvR2ZZTTZWSGV0Q0pQVFZSdGlaal9VTGNaOThEWm5QeHFnLWlXblBWY2taZVR0WjhMeURTNjF0c25WREU3VHc?oc=5","date":"2026-03-09","type":"trial","source":"Yahoo Finance","summary":"InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial - Yahoo Finance","headline":"InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical T","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVVlkNTRWUnR0eURuMThRS2NrVlZhek9KWVgyd0F5MHN2U2EyQzMtMzRkN3Z0MkhGQUhJZ013ekUzUkxzcHhFM0haZ2VqQ2lKTFZDSUF5Y291cVludGJXWEx6YWpST0RxVDd1SnByREw5UVBZOWdjVFFLRnhiTUtWc2F0SEpPejNvenBuUFNONTZsS19uTlktbExNUm9wbWZpVkI2NkFiajE2WERtbHZlSWNJZllhNGhm?oc=5","date":"2026-03-06","type":"pipeline","source":"Stock Titan","summary":"U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs - Stock Titan","headline":"U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOTldjZHJ5MkRYdS1NSzNORGRwSFlEN1QzNmhvbGZrNVh2TVJpaWMtd0tCbElCTDZUVXZlVVZuUndMeDVrOC1NRUhkenRNS0wwcWIxcHJKbnRweW5VQmR4MHZvQ1E1MXdBaUFReFZTVk9DRlNLWnhKc0dPYVRaM0xzQ2hkT1g0dERoUUdWN0JrUlZnUXVJVFRqdFptVVhCbjJVa0F2NXV6MElJcUJ6OGFnZ0ZwTF9Ub2M0UlcwYlVrTTJodUpiRFFNVm5ScWc4YUVpNmJhZE1kNE5uazBCRTRxVjJQQmc?oc=5","date":"2026-03-06","type":"pipeline","source":"TMX Newsfile","summary":"InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - TMX Newsfile","headline":"InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-02-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNTTl4V1JlMU5BMlVBQUNwaEtoVzdYT0VuYXBDcDR5NUhBY25TSDlISHlnOFU1bHE0UDZ1T1pFdkxTSGtYbHNZOVc4Sk9mekpkUkNCT3g3bnpuX2YtTkVScFRubmZ1ZHV0dlpNSTBqZGJGdkJhZmtIRWxMTzUwSklfb0hTN0lPMW81Zk5wUGdBbzdoUWNaMFQ1bGZZWjR3Nk5qTFRnakVtM3lHaWVTRTlSczJ1X2FkMmppTlNfMG5Udk5VQ0FGUGI4ektOMA?oc=5","date":"2026-02-11","type":"earnings","source":"TMX Newsfile","summary":"InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - TMX Newsfile","headline":"InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update","sentiment":"neutral"},{"date":"2026-02-11","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPYXhuU2lhT1ZocElPVHNUYlJzam1kRzVSYTN2U3p0VERBcGEwSy1kVHBSalJhSVVFVGZtREFzQVdjSnZiakxiOUhsTHROR2c1dFV5M1R0M05IcW5uUjVDeXE1X0RBVzFqamFoSC1ETE9sdDV3R0tzYV9iVmlGM1JVWmVRN2N2R2JE?oc=5","date":"2025-12-12","type":"pipeline","source":"investingnews.com","summary":"InMed Provides Update on BayMedica Commercial Business - investingnews.com","headline":"InMed Provides Update on BayMedica Commercial Business","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":4942633,"revenuePeriod":"2025-06-30","revenueHistory":[{"value":4942633,"period":"2025-06-30"},{"value":4597730,"period":"2024-06-30"},{"value":4597730,"period":"2024-06-30"},{"value":4135561,"period":"2023-06-30"},{"value":4135561,"period":"2023-06-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":2853920,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-8162133,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":15580040,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}